Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Mounjaro, DailyMed (2024) Savings & resources, Eli Lilly and Company (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) An open letter from Eli Lilly and Company regarding certain practices related to Mounjaro and Zepbound, Eli Lilly (2024) Compounding and the FDA: Questions and answers, Food and Drug Administration (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
For the broader picture across both molecules, our GLP-1 hub and our best tirzepatide page go deeper
Ready to start your GLP-1 journey with GobyMeds
What are the best high-protein foods for GLP-1 users
If this is true at an individual level, its even more true at a population level
This variation reflects differences in GLP-1 receptor density and downstream signaling efficiency, not medication quality or patient compliance